The mission of the Office of Translational Research is to facilitate the preclinical discovery and development of new therapeutic interventions for neurological disorders by:
Scientific Staff | Research Area |
Jill Heemskerk, Ph.D. Program Director |
High Throughput Drug Screening, SMA therapeutics development, Medicinal Chemistry |
David Jett, Ph.D. Program Director |
Counterterrorism (CounterACT) Programs, Neurotoxicology |
Yuan Liu, Ph.D. Chief, Office of International Activities |
Neuroimaging informatics, Bioinformatics, Computational Neuroscience |
Thomas Miller, Ph.D., M.B.A. Program Director |
Preclinical Development of Therapeutics, Research Infrastructure |
Mark Scheideler, Ph.D. Program Analyst |
Roadmap Molecular Libraries |
James Stables, MS Admin., R.Ph. Program Director, Office Director |
Anti-Convulsant Screening Program |
Stacey Chambers Program Analyst |
|
Lydia Munger Program Analyst |